Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model

Human Gene Therapy

Volumn 25, Issue 12, 2014, Pages 1023-1034

  Ling, Chen ^a   Wang, Yuan ^a,b,c   Zhang, Yuanhui ^a,b,c   Ejjigani, Anila ^b   Yin, Zifei ^a,b   Lu, Yuan ^a   Wang, Lina ^a,b   Wang, Meng ^b,c   Li, Jun ^b   Hu, Zhongbo ^a   Aslanidi, George V ^a   Zhong, Li ^d   Gao, Guangping ^d   Srivastava, Arun ^a,e   Ling, Changquan ^b,c,f  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

^f Shanghai Municipal Education Commission   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; SERINE; SHIKONIN; THREONINE;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CANCER GROWTH; CELL INTERACTION; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GENE EXPRESSION; GENETIC TRANSDUCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER INJURY; LIVER TUMOR; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; TRANSGENE; TUMOR XENOGRAFT; VIRAL CLEARANCE; VIRAL GENE DELIVERY SYSTEM; VIRAL TROPISM; VIRUS CAPSID; VIRUS RECOMBINANT; ANIMAL; DEPENDOPARVOVIRUS; DISEASE MODEL; DRUG SCREENING; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; LIVER CELL; LIVER NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

ADENO-ASSOCIATED VIRUS; MIRIDAE; MURINAE;

ANIMALS; CELL LINE, TUMOR; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MICE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84918806026     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2014.099     Document Type: Article

References (53)

1. Aslanidi, G.V., Rivers, A.E., Ortiz, L., et al. (2012). Highefficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors. Vaccine 30, 3908-3917
2. Aslanidi, G.V., Rivers, A.E., Ortiz, L., et al. (2013). Optimization of the capsid of recombinant adeno-Associated virus 2 (AAV2) vectors: The final threshold? PLoS One 8, e59142
3. Chen, W.Q., Zheng, R.S., and Zhang, S.W. (2013). Liver cancer incidence and mortality in China, 2009. Chin. J. Cancer 32, 162-169
4. Cheng, B., Ling, C., Dai, Y., et al. (2012).Development of optimized AAV3 serotype vectors: Mechanism of high-efficiency transduction of human liver cancer cells. Gene Ther. 19, 375-384
5. Dai, Y., and Siemann, D.W. (2010). Bms-777607, a smallmolecule met kinase inhibitor, suppresses hepatocyte growth factor-stimulated prostate cancer metastatic phenotype in vitro. Mol. Cancer Ther. 9, 1554-1561
6. Dai, Y., Bae, K., and Siemann, D.W. (2011). Impact of hypoxia on the metastatic potential of human prostate cancer cells. Int. J. Radiat. Oncol. Biol. Phys. 81, 521-528
7. Davidoff, A.M., Ng, C.Y., Zhou, J., et al. (2003). Sex significantly influences transduction of murine liver by recombinant adeno-Associated viral vectors through an androgen-dependent pathway. Blood 102, 480-488
8. Dong, S., and Su, S.B. (2014). Advances in mesenchymal stem cells combined with traditional chinese medicine therapy for liver fibrosis. J. Integr. Med. 12, 147-155
9. El-Serag, H.B. (2011). Hepatocellular carcinoma. N. Engl. J. Med. 365, 1118-1127
10. Gao, G.P., Alvira, M.R., Wang, L., et al. (2002). Novel adenoassociated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 99, 11854-11859
11. Ginn, S.L., Alexander, I.E., Edelstein, M.L., et al. (2013). Gene therapy clinical trials worldwide to 2012-An update. J. Gene Med. 15, 65-77
12. Glushakova, L.G., Lisankie, M.J., Eruslanov, E.B., et al. (2009). AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells. Mol. Genet. Metab. 98, 289-299
13. Gong, K., and Li, W. (2011). Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma. Free Radic. Biol. Med. 51, 2259-2271
14. Gu, Y., Lin, S., Li, J.L., et al. (2012). Altered LKB1/CREBregulated transcription co-Activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion. Oncogene. 31, 469-479
15. Hsu, S.H., Wang, B., Kota, J., et al. (2012). Essential metabolic, anti-inflammatory, and anti-Tumorigenic functions of mir-122 in liver. J. Clin. Invest. 122, 2871-2883
16. Jemal, A., Bray, F., Center, M.M., et al. (2011). Global cancer statistics. CA Cancer J. Clin. 61, 69-90
17. Kunick, C., Lauenroth, K., Leost, M., et al. (2004). 1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3 beta. Bioorg. Med. Chem. Lett. 14, 413-416
18. Lin, S., Shen, H., Li, J.L., et al. (2013). Proteomic and functional analyses reveal the role of chromatin reader SFMBT1 in regulating epigenetic silencing and the myogenic gene program. J. Biol. Chem. 288, 6238-6247
19. Lin, S., Tian, L., Shen, H., et al. (2013). Ddx5 is a positive regulator of oncogenic notch1 signaling in T cell acute lymphoblastic leukemia. Oncogene 32, 4845-4853
20. Ling, C., Lu, Y., Kalsi, J.K., et al. (2010). Human hepatocyte growth factor receptor is a cellular coreceptor for adenoassociated virus serotype 3. Hum. Gene Ther. 21, 1741-1747
21. Ling, C., Lu, Y., Cheng, B., et al. (2011). High-efficiency transduction of liver cancer cells by recombinant adenoassociated virus serotype 3 vectors. J. Vis. Exp
22. Ling, C.Q., Wang, L.N., Wang, Y., et al. (2014). The roles of traditional Chinese medicine in gene therapy. J. Integr. Med. 12, 67-75
23. Ling, C.Q., Yue, X.Q., and Ling, C. (2014). Three advantages of using traditional Chinese medicine to prevent and treat tumor. J. Integr. Med. 12, 331-335
24. Lisowski, L., Dane, A.P., Chu, K., et al. (2014). Selection and evaluation of clinically relevant AAV variants in a xenograft liver model. Nature 506, 382-386
25. Liu, Y., Joo, K.I., and Wang, P. (2012). Endocytic processing of adeno-Associated virus type 8 vectors for transduction of target cells. Gene Ther. 20, 308-317
26. Liu, Y., Fang, J., Kim, Y.J., et al. (2014). Codelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activity. Mol. Pharm. 11, 1651-1661
27. Llovet, J.M., Ricci, S., Mazzaferro, V., et al. (2008). Sorafenib in advanced hepatocellular carcinoma. N. Engl. J. Med. 359, 378-390
28. Markakis, E.A., Vives, K.P., Bober, J., et al. (2010). Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain. Mol. Ther. 18, 588-593
29. Markusic, D.M., Herzog, R.W., Aslanidi, G.V., et al. (2010). High-efficiency transduction and correction of murine hemophilia b using aav2 vectors devoid of multiple surfaceexposed tyrosines. Mol. Ther. 18, 2048-2056
30. Melchiorri, D., Pani, L., Gasparini, P., et al. (2013). Regulatory evaluation of Glybera in Europe-Two committees, one mission. Nat. Rev. Drug Discov. 12, 719
31. Messina, E.L., Nienaber, J., Daneshmand, M., et al. (2012). Adenoassociated viral vectors based on serotype 3b use components of the fibroblast growth factor receptor signaling complex for efficient transduction. Hum. Gene Ther. 23, 1031-1042
32. Mingozzi, F., and High, K.A. (2011). Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges. Nat. Rev. Genet. 12, 341-355
33. Mitchell, A.M., Li, C., and Samulski, R.J. (2013). Arsenic trioxide stabilizes accumulations of adeno-Associated virus virions at the perinuclear region, increasing transduction in vitro and in vivo. J. Virol. 87, 4571-4583
34. Nathwani, A.C., Gray, J.T., Ng, C.Y., et al. (2006). Selfcomplementary adeno-Associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. Blood 107, 2653-2661
35. Nathwani, A.C., Gray, J.T., McIntosh, J., et al. (2007). Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human fix in nonhuman primates. Blood 109, 1414-1421
36. Pandya, J., Ortiz, L., Ling, C., et al. (2013). Rationally designed capsid and transgene cassette of AAV6 vectors for dendritic cell-based cancer immunotherapy. Immunol. Cell Biol. 92, 116-123
37. Peng, D., Qian, C., Sun, Y., et al. (2000). Transduction of hepatocellular carcinoma (HCC) using recombinant adenoassociated virus (rAAV): In vitro and in vivo effects of genotoxic agents. J. Hepatol. 32, 975-985
38. Rabinowitz, J.E., Bowles, D.E., Faust, S.M., et al. (2004). Cross-dressing the virion: The transcapsidation of adenoassociated virus serotypes functionally defines subgroups. J. Virol. 78, 4421-4432
39. Sha, O., Niu, J., Ng, T.B., et al. (2013). Anti-Tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: A mini review. Cancer Chemother. Pharmacol. 71, 1387-1393
40. Song, H.Y., Zhang, L., Pan, J.L., et al. (2013). Bioactivity of five components of Chinese herbal formula jiangzhi granules against hepatocellular steatosis. J. Integr. Med. 11, 262-268
41. Su, H., Lu, R., Ding, R., and Kan, Y.W. (2000). Adeno-Associated viral-mediated gene transfer to hepatoma: Thymidine kinase/interleukin 2 is more effective in tumor killing in nonganciclovir (GCV)-Treated than in GCV-Treated animals. Mol. Ther. 1, 509-515
42. Verslype, C., Van Cutsem, E., Dicato, M., et al. (2009). The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. Ann. Oncol. 20 Suppl 7, vii1-vii6
43. Wang, Z., Zhu, T., Qiao, C., et al. (2005). Adeno-Associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat. Biotechnol. 23, 321-328
44. Wang, L.N., Wang, Y., Lu, Y., et al. (2014). Pristimerin enhances recombinant adeno-Associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivo. J. Integr. Med. 12, 20-34
45. Yang, H., Zhou, P., Huang, H., et al. (2009). Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo. Int. J. Cancer 124, 2450-2459
46. You, H., Ding, W., Dang, H., et al. (2011). C-met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma. Hepatology 54, 879-889
47. Zhai, X.F., Chen, Z., Li, B., et al. (2013). Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: A multicenter randomized controlled trial. J. Integr. Med. 11, 90-100
48. Zhang, F.L., Jia, S.Q., Zheng, S.P., and Ding, W. (2010). Celastrol enhances AAV1-mediated gene expression in mice adipose tissues. Gene Ther. 18, 128-134
49. Zhang, Y., Wang, Y., Yusufali, A., et al. (2014) Cytotoxic genes from traditional Chinese medicine inhibit tumor growth both in vitro and in vivo. J. Integr. Med. (In press
50. Zhang, Y., Zhao, L., Li, X., et al. (2014). V8, a newly synthetic flavonoid, induces apoptosis through ROS-mediated ER stress pathway in hepatocellular carcinoma. Arch. Toxicol. 88, 97-107
51. Zhong, L., Li, B., Mah, C.S., et al. (2008). Next generation of adeno-Associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc. Natl. Acad. Sci. USA 105, 7827-7832
52. Zhu, B., Zhao, L., Zhu, L., et al. (2012). Oroxylin A reverses CAM-DR of HepG2 cells by suppressing Integrinb1 and its related pathway. Toxicol. Appl. Pharmacol. 259, 387-394
53. Zincarelli, C., Soltys, S., Rengo, G., and Rabinowitz, J.E. (2008). Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol. Ther. 16, 1073-1080